Preclinical Study of Combination of Antifolate Agents with Palbociclib Isethionate to Treat Mantle Cell Lymphoma with or without P53 Deficiency
Mantle cell lymphoma (MCL) carries an unfavorable prognosis and easily relapse and resistance especially MCL with P53 deficiency so that requires new treatment strategies.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Huihan Wang, Xiaobin Wang, Richard Jones, Isere Kuiatse, Hua Wang, Robert Orlowski Source Type: research